Pacific Shuanglin Bio-pharmacy Co., Ltd.

Pacific Shuanglin Bio-pharmacy Co., Ltd.

Share · CNE000000F14 (XSHE)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Pacific Shuanglin Bio-pharmacy Co., Ltd.
No Price
Closing Price XSHE 29.04.2026: 12,17 CNY
29.04.2026 07:04
Current Prices from Pacific Shuanglin Bio-pharmacy Co., Ltd.
ExchangeTickerCurrencyLast TradePriceDaily Change
XSHE: SHENZHEN STOCK EXCHANGE
SHENZHEN STOCK EXCHANGE
000403.SZ
CNY
29.04.2026 07:04
12,17 CNY
-0,11 CNY
-0,90 %
Share Float & Liquidity
Free Float 56,48 %
Shares Float 536,8 M
Shares Outstanding 950,4 M
Company Profile for Pacific Shuanglin Bio-pharmacy Co., Ltd. Share
Pacific Shuanglin Bio-pharmacy Co., Ltd. engages in the biochemical engineering, pharmaceutical industry equipment, and medical materials businesses in China. Its lead products include human serum albumin, human immunoglobulin, intravenous human immunoglobulin (PH4), human rabies immunoglobulin, hepatitis B human immunoglobulin, tetanus human immunoglobulin, tianqi analgesic cream, musk herd cream, musk bone paste, anti-inflammatory analgesic cream, dieshangling plasters, and medical gauzes. The company is also involved in the development of porcine pulmonary surfactants, shaqifang compounds, a1-protease inhibitors, human coagulation factor VIII products, and human fibrinogens. In addition, it engages in the investment, consultation, and technology promotion of pharmaceutical and biotechnology development projects; real estate development; and electronic product information consultation, as well as in the provision of electricity. The company was formerly known as Southern Shuanglin Bio-pharmacy Co., Ltd. and changed its name to Pacific Shuanglin Bio-pharmacy Co., Ltd. in April 2021. Pacific Shuanglin Bio-pharmacy Co., Ltd. is based in Taiyuan, China.

Company Data

Name Pacific Shuanglin Bio-pharmacy Co., Ltd.
Company Pacific Shuanglin Bio-pharmacy Co., Ltd.
Website https://www.slbiop.com
Primary Exchange XSHE SHENZHEN STOCK EXCHANGE
ISIN CNE000000F14
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Xiankui Rong
Market Capitalization 12 Mrd.
Country China
Currency CNY
Employees 2,6 T
Address High-Tech International Building, 030006 Taiyuan
IPO Date 2013-02-08
Dividends from 'Pacific Shuanglin Bio-pharmacy Co., Ltd.'
Ex-Date Dividend per Share
04.06.2025 0,27 CNY
17.12.2024 0,12 CNY
28.06.2024 0,15 CNY
20.07.2023 0,06 CNY
15.07.2022 0,04 CNY
27.07.2020 0,09 CNY

Stock Splits

Date Split
27.07.2020 1952679:1000000
08.02.2013 8:5

Ticker Symbols

Name Symbol
SHENZHEN STOCK EXCHANGE 000403.SZ
More Shares
Investors who hold Pacific Shuanglin Bio-pharmacy Co., Ltd. also have the following shares in their portfolio:
DWS INVEST ESG USD CORPRATE BONDS USD LD
DWS INVEST ESG USD CORPRATE BONDS USD LD Fund
EATON VANCE TAX-ADVANTAGED GLOBAL DIVIDEND INCME FUND  OF BENEFICIAL INTEREST
EATON VANCE TAX-ADVANTAGED GLOBAL DIVIDEND INCME FUND OF BENEFICIAL INTEREST Fund